Equillium, Inc. (LON:0A4D)
London
· Delayed Price · Currency is GBP · Price in USD 0.3605
-0.0255 (-6.61%)
At close: Jul 10, 2025
Equillium Revenue
Equillium had revenue of $30.41M USD in the twelve months ending March 31, 2025, down -19.76% year-over-year. In the year 2024, Equillium had annual revenue of $41.10M with 13.89% growth.
Revenue (ttm)
$30.41M
Revenue Growth
-19.76%
P/S Ratio
0.43
Revenue / Employee
$868.74K
Employees
35
Market Cap
10.16M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |